MeSH term
Frequency | Condition_Probility | Base Sequence | 3 | 0.0 |
Chromatography, High Pressure Liquid/*methods | 2 | 1.0 |
Dihydrouracil Dehydrogenase (NADP) | 10 | 62.0 |
Exons/genetics | 3 | 0.0 |
Genotype | 6 | 0.0 |
Humans | 22 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Oxidoreductases/*deficiency/*genetics | 2 | 33.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Comparative Study | 5 | 0.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Female | 8 | 0.0 |
Male | 9 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Neoplasms/*drug therapy | 3 | 2.0 |
Alleles | 2 | 0.0 |
Antimetabolites, Antineoplastic/*toxicity | 2 | 28.0 |
Fluorouracil/*toxicity | 2 | 50.0 |
Mutation | 3 | 0.0 |
Phenotype | 4 | 0.0 |
RNA Splicing | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 8 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Antimetabolites, Antineoplastic/*pharmacology | 2 | 2.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Fluorouracil/*pharmacology | 2 | 5.0 |
Forecasting | 2 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
*Models, Theoretical | 2 | 3.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Predictive Value of Tests | 2 | 0.0 |
Regression Analysis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Stomach Neoplasms/*drug therapy/*genetics | 2 | 100.0 |
Adult | 5 | 0.0 |
Aged | 6 | 0.0 |
Amino Acids/urine | 2 | 6.0 |
Blood Sedimentation | 2 | 1.0 |
Middle Aged | 6 | 0.0 |
Oxidoreductases/deficiency/*genetics | 2 | 16.0 |
Pharmacogenetics | 2 | 1.0 |
Sensitivity and Specificity | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Protein Conformation | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Methyltransferases/genetics | 2 | 11.0 |
